Invitae Growth, Revenue, Number of Employees and Funding

Overview

Location:
Total Funding:$195.5M
Industry:Biotech
Founded:2010
Lead Investor(s):J.P. Morgan Securities LLC, Cowen and Company, LLC
Press

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Invitae's estimated revenue is currently $147.7M per year.
  • Invitae received $143.8M in venture funding in March 2019.
  • Invitae's estimated revenue per employee is $197723
  • Invitae's total funding is $195.5M.

Employee Data

  • Invitae has 747 Employees.
  • Invitae grew their employee count by 27% last year.
  • Invitae currently has 128 job openings.

What Is Invitae?

Invitae is a genetic information company whose mission is to bring genetic information into routine medical practice to improve the quality of healthcare for billions of people. Specializing in genetic diagnostics for hereditary disorders, Invitae is aggregating the world's genetic tests into a single service with better quality, faster turnaround time, and a lower price than most single-gene diagnostic tests today. Choose from our curated panels or design your own test for the same low price. Today, we are reinventing genetic testing by lowering the barriers for clinicians and patients to obtain diagnostic genetic information. Together we can improve healthcare for billions of people.

keywords:Biotechnology,E-Commerce,Healthcare,Medical Diagnostics,Pharmaceuticals

747

Number of Employees

$147.7M

Revenue (est)

128

Current Jobs

27%

Employee Growth %

$195.5M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Mission Bio
$7.4M6944%
Rigel Pharmaceu...
$40.5M2714%
ProTrials Resea...
$25.6M1703%
Advanced Cell D...
$23.9M1668%
CellMax Life
$10M379%$9M
Atreca
$10.7M8117%
Full Spectrum A...
$5.7M395%
Pipette.com/Acc...
N/AN/A
Irvine Scientif...
$29.1M2059%
Talis Biomedica...
$8.1M544%

Invitae News

12-Sep-19 - Invitae Expands Detect Program to Offer No-Charge Genetic ...

Detect sponsored testing programs are designed to overcome barriers to testing and connect patients to earlier diagnosis and treatments -.

07-Sep-19 - Invitae Prices Upsized Offering of $300 Million of Convertible ...

SAN FRANCISCO, Sept. 6, 2019 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA) announced the pricing on September 5, 2019 of $300.0 ...

12-Sep-19 - Invitae (NVTA) Dips More Than Broader Markets: What You ...

Invitae (NVTA) Dips More Than Broader Markets: What You Should Know ... Invitae Corporation (NVTA): Free Stock Analysis Report

Invitae Funding

DateAmountRoundLead InvestorsReference
2013-12-11$40.0MEArticle
2014-10-14$120.0MFMultipleArticle
2016-11-18$44.0MUndisclosedJ.P. Morgan Securities LLCArticle
2018-02-28$40.0MUndisclosedOxford Finance, LLCArticle
2018-03-27$57.5MUndisclosedJ.P. Morgan Securities LLCArticle
2019-03-05$143.8MUndisclosedJ.P. Morgan Securities LLCArticle

Invitae Executive Hires

DateNameTitleReference
2017-01-10Sean GeorgeCEOArticle
2017-05-26Shelly GuyerCFOArticle

Invitae Acquisitions

DateCompany NameAmountNotesReference
2017-01-09AltaVoice (formerly PatientCrossroadsStock Deal -Not CompleteArticle
2017-06-13CancerGeneConnectArticle
2017-08-01Good Start Genetics, IncArticle
2017-11-16CombiMatrix CorporationArticle